Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
F 87.06 2.12% 1.81
SRPT closed up 2.12 percent on Friday, February 26, 2021, on 70 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical SRPT trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Pocket Pivot Bullish Swing Setup 2.12%
Lower Bollinger Band Walk Weakness 2.12%
Earnings Movers Other 2.12%
Outside Day Range Expansion 2.12%
Older End-of-Day Signals for SRPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sarepta Therapeutics, Inc. Description

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Clinical Development Infectious Diseases Rare Diseases Clinical Research Influenza Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Therapeutic Gene Modulation Antisense RNA Antisense Therapy Sarepta Therapeutics

Is SRPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 181.83
52 Week Low 77.01
Average Volume 2,185,305
200-Day Moving Average 141.05
50-Day Moving Average 116.56
20-Day Moving Average 89.73
10-Day Moving Average 86.88
Average True Range 5.30
ADX 34.5
+DI 16.73
-DI 30.27
Chandelier Exit (Long, 3 ATRs ) 80.99
Chandelier Exit (Short, 3 ATRs ) 92.90
Upper Bollinger Band 97.41
Lower Bollinger Band 82.05
Percent B (%b) 0.33
BandWidth 17.12
MACD Line -6.94
MACD Signal Line -8.22
MACD Histogram 1.2788
Fundamentals Value
Market Cap 6.87 Billion
Num Shares 78.9 Million
EPS -8.14
Price-to-Earnings (P/E) Ratio -10.70
Price-to-Sales 23.81
Price-to-Book 13.56
PEG Ratio 159.25
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 95.07
Resistance 3 (R3) 94.36 90.99 93.74
Resistance 2 (R2) 90.99 88.95 91.34 93.29
Resistance 1 (R1) 89.02 87.69 90.01 89.73 92.84
Pivot Point 85.65 85.65 86.14 86.00 85.65
Support 1 (S1) 83.68 83.61 84.67 84.39 81.28
Support 2 (S2) 80.31 82.35 80.66 80.83
Support 3 (S3) 78.34 80.31 80.39
Support 4 (S4) 79.05